MARKET

BRKR

BRKR

Bruker
NASDAQ

Real-time Quotes | Nasdaq Last Sale

44.01
+0.37
+0.85%
Opening 11:50 08/12 EDT
OPEN
43.95
PREV CLOSE
43.64
HIGH
44.16
LOW
43.83
VOLUME
34.84K
TURNOVER
--
52 WEEK HIGH
54.49
52 WEEK LOW
30.78
MARKET CAP
6.74B
P/E (TTM)
41.57
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 15 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BRKR stock price target is 47.92 with a high estimate of 54.00 and a low estimate of 43.00.

EPS

BRKR News

More
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins
Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins
Business Wire · 2d ago
Bruker Announces Quarterly Dividend
Bruker Announces Quarterly Dividend
Business Wire · 5d ago
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
Business Wire · 5d ago
Bruker (BRKR) Q2 Earnings Surpass Estimates, Margins Fall
Bruker's (BRKR) second-quarter 2020 results reflect dismal performance by all segments and geographies due to coronavirus-led business disruptions.
Zacks · 08/04 14:40
Citigroup Maintains Neutral on Bruker, Raises Price Target to $47
Citigroup maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $38 to $47.
Benzinga · 08/04 13:54
Bruker Q2 top line down 13%, earnings off 34% due to pandemic
Bruker (NASDAQ:BRKR) Q2 results: Revenues: $424.6M (-13.4%); BioSpin: $125.1M (-17.1%); CALID: $132.7M (-5.6%); Nano: $125.5M (-16.9%). Revenues pressured
seekingalpha · 08/04 01:36
Bruker: Q2 Earnings Insights
Shares of Bruker (NASDAQ:BRKR) moved higher by 0.06% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 36.36% year over year to $0.21, which beat the estimate of $0.06.Revenue of $424,600,000 declined by 13
Benzinga · 08/03 20:57
Bruker Q2 Adj. EPS $0.21 Beats $0.06 Estimate, Sales $424.60M Beat $390.92M Estimate
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.06 by 250 percent. This is a 36.36 percent decrease over earnings of $0.33 per share from the same
Benzinga · 08/03 20:21

Industry

Advanced Medical Equipment & Technology
+1.78%
Healthcare Equipment & Supplies
+1.65%

Hot Stocks

Symbol
Price
%Change

About BRKR

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.
More

Webull offers kinds of Bruker Corporation stock information, including NASDAQ:BRKR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRKR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BRKR stock methods without spending real money on the virtual paper trading platform.